BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12747593)

  • 1. Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis.
    Harrington DJ; Malefora A; Schmeleva V; Kapustin S; Papayan L; Blinov M; Harrington P; Mitchell M; Savidge GF
    Clin Chem Lab Med; 2003 Apr; 41(4):496-500. PubMed ID: 12747593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease.
    Couturaud F; Oger E; Abalain JH; Chenu E; Guias B; Floch HH; Mercier B; Mottier D; Leroyer C
    Respiration; 2000; 67(6):657-61. PubMed ID: 11124649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
    Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
    Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
    Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.
    Lu Y; Zhao Y; Liu G; Wang X; Liu Z; Chen B; Hui R
    Thromb Res; 2002 Apr; 106(1):7-12. PubMed ID: 12165282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
    Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
    Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism.
    Salomon O; Rosenberg N; Zivelin A; Steinberg DM; Kornbrot N; Dardik R; Inbal A; Seligsohn U
    Hematol J; 2001; 2(1):38-41. PubMed ID: 11920232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.
    Grandone E; Margaglione M; Colaizzo D; D'Andrea G; Cappucci G; Brancaccio V; Di Minno G
    Am J Obstet Gynecol; 1998 Nov; 179(5):1324-8. PubMed ID: 9822524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population.
    Zheng YZ; Tong J; Do XP; Pu XQ; Zhou BT
    Br J Haematol; 2000 Jun; 109(4):870-4. PubMed ID: 10929044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
    Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
    Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
    Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
    Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
    Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
    Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
    Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
    Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.